Use of direct oral anticoagulants in the first year after market entry of edoxaban: A Danish nationwide drug utilization study

作者
Anton Pottegård,Erik Lerkevang Grove,Maja Hellfritzsch
出处
期刊:Pharmacoepidemiology and Drug Safety [Wiley]
卷期号:27 (2): 174-181 被引量:19
标识
DOI:10.1002/pds.4350
摘要

OBJECTIVES: To describe the early uptake of edoxaban; the fourth direct oral anticoagulant (DOAC) to enter the market. METHODS: Using the Danish nationwide health registries, we identified new users of edoxaban (n = 609) from June 6 (day of marketing) through June 2017. For comparison, we also identified new users of dabigatran (n = 2211), rivaroxaban (n = 19 227), and apixaban (n = 14 736). Users were described regarding indication of use, previous anticoagulant experience, comorbidity, and co-medication. RESULTS: The rate of edoxaban initiation increased to 2.0 per 100 000 person months in June 2017, compared with 6.3, 37.5, and 27.0 for dabigatran, rivaroxaban, and apixaban. Atrial fibrillation was the most common registered indication for edoxaban (67%) as well as the other DOACs (41-55%). Overall, users of edoxaban were comparable to users of other DOACs (median age 75 vs 72-76 years and 57% vs 53-59% males), except for a generally lower concomitant use of other drugs. Noticeably, 95% of edoxaban users had previously received anticoagulant treatment compared with 31% to 43% for new users of other DOACs, with 77% switching directly from another anticoagulant treatment to edoxaban (45% directly from VKA and 32% directly from DOACs). CONCLUSIONS: While the use of edoxaban is still limited compared with other DOACs, it is increasing. The majority of edoxaban users switch to edoxaban from other anticoagulant treatments. Continued monitoring of the utilization of DOACs, including effectiveness and safety, is considered essential to the safe and rational use of these drugs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
包容的小松鼠完成签到,获得积分10
刚刚
研狗发布了新的文献求助20
1秒前
4秒前
科研辣鸡发布了新的文献求助10
4秒前
4秒前
5秒前
5秒前
HHW发布了新的文献求助10
5秒前
yunyueqixun完成签到,获得积分10
5秒前
Adieu完成签到,获得积分20
5秒前
塔塔发布了新的文献求助10
6秒前
原子发布了新的文献求助10
6秒前
6秒前
未完成完成签到,获得积分0
7秒前
DDC完成签到,获得积分10
8秒前
希望天下0贩的0的应助被SFF采纳,获得10
8秒前
李麟完成签到,获得积分10
8秒前
9秒前
阿孟孟完成签到 ,获得积分10
10秒前
zy完成签到,获得积分20
10秒前
10秒前
我是谁的应助被李瑞程采纳,获得30
11秒前
11秒前
11秒前
11秒前
lsq108发布了新的文献求助10
11秒前
可爱的函函的应助被苏小咩采纳,获得10
11秒前
liangye2222发布了新的文献求助10
12秒前
acer08完成签到,获得积分10
12秒前
小叶子的太阳完成签到,获得积分10
12秒前
牛战士完成签到,获得积分10
12秒前
虚心的凡霜完成签到,获得积分10
13秒前
我是老大的应助被真实的立轩采纳,获得30
13秒前
13秒前
Ma发布了新的文献求助10
14秒前
15秒前
15秒前
在水一方的应助被崖林采纳,获得10
15秒前
lyj发布了新的文献求助10
16秒前
bkagyin的应助被忐忑的马里奥采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183324
求助须知:如何正确求助?哪些是违规求助? 9572627
关于积分的说明 21826529
捐赠科研通 7780320
什么是DOI,文献DOI怎么找? 3433993
关于科研通互助平台的介绍 2558155
邀请新用户注册赠送积分活动 2480290